<SEC-DOCUMENT>0001628280-21-023902.txt : 20211119
<SEC-HEADER>0001628280-21-023902.hdr.sgml : 20211119
<ACCEPTANCE-DATETIME>20211119171705
ACCESSION NUMBER:		0001628280-21-023902
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20211119
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211119
DATE AS OF CHANGE:		20211119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		211429336

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cpix-20211119.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d9de5e93-697f-42b2-ad33-b7c537767821,g:b6819b24-3bab-4059-a559-788a40dfb1b8,d:cd1614bd640146b1b5628808d14e373e--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cpix-20211119</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xMC9mcmFnOjYxZjRjM2E5YTc5ZDQzMzNhMWMyZTBiYWVkYzcxNTAzL3RhYmxlOmQ2YzdiNzRiNzg2ZTQ3YTdiYWIzMmQ0MWNiOGRkYWFlL3RhYmxlcmFuZ2U6ZDZjN2I3NGI3ODZlNDdhN2JhYjMyZDQxY2I4ZGRhYWVfMi0xLTEtMS0xMjAxNA_0d36e5d1-c96f-4507-9db3-816c70f6a717">0001087294</ix:nonNumeric><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xMC9mcmFnOjYxZjRjM2E5YTc5ZDQzMzNhMWMyZTBiYWVkYzcxNTAzL3RhYmxlOmQ2YzdiNzRiNzg2ZTQ3YTdiYWIzMmQ0MWNiOGRkYWFlL3RhYmxlcmFuZ2U6ZDZjN2I3NGI3ODZlNDdhN2JhYjMyZDQxY2I4ZGRhYWVfMy0xLTEtMS0xMjAxNA_9c2d463c-9b1f-488f-a6c9-12ef25165b3d">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cpix-20211119.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001087294</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-19</xbrli:startDate><xbrli:endDate>2021-11-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icd1614bd640146b1b5628808d14e373e_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:144%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%">FORM <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAx_06e7df26-a4c7-45ec-bee5-2f558c4d7794">8-K</ix:nonNumeric> </span></div><div style="margin-top:11pt;padding-left:108pt;padding-right:108pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzc_4a7c2e20-66db-4572-98a1-4ac2ea4b9807">November 19, 2021</ix:nonNumeric> (November 15, 2021)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAy_5a261728-20cd-4d32-86b1-6fa8de77c4b1">CUMBERLAND PHARMACEUTICALS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTAtMS0xLTEyMDE0_edb3bafa-42c1-44d3-8d6c-03c3ffed22cd">Tennessee</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTEtMS0xLTEyMDE0_757cf74e-0442-4168-b9c6-be9d590046e4">001-33637</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTMtMS0xLTEyMDE0_03db626d-c6c7-4ac0-9fc2-24207bdbcbfc">62-1765329</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk1_a45d2f15-8b68-4e8f-94a8-5d574d31d78b">2525 West End Avenue, Suite 950</ix:nonNumeric> <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAz_c8a1152c-cc89-4527-a752-5ed334f71c8c">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk3_1fda035e-3fdb-4fbc-a56e-d2edc4ea49ed">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk4_d018e038-a362-4275-bf15-9bd9b2b73663">37203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(Address of Principal Executive Offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk5_d2c34050-d5a8-483b-8b44-4788484c6fc5">615</ix:nonNumeric>) <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA0_8a1cdf4c-57b9-4c11-8672-122c2ffe9e1e">255-0068</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Registrant's telephone number, including area code</span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk2_9e6c407e-e172-417e-adfb-d2b8cf2c996f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk0_57ba37b3-2f04-4113-8db3-af27ebef0dc7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA1_7258ea6c-720b-44e6-b475-3541790ef40c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA2_45d9f30d-c5e5-4ef4-b58d-8a01eee6809a">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.160%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTAtMS0xLTEyMDE0_0723e2ba-aac5-4548-89cc-df3ac6f97292">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTEtMS0xLTEyMDE0_6f7a5966-7a3f-4a04-886c-0c576bbbde05">CPIX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTItMS0xLTEyMDE0_2118e7b5-4869-4982-9297-d69fb0af283a">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAw_5ca26458-edce-423b-9a5e-5e7526086a4c">&#9744;</ix:nonNumeric></span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8yMTk5MDIzMjU3Mjk5_5ca26458-edce-423b-9a5e-5e7526086a4c">&#9744;</ix:nonNumeric></span></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icd1614bd640146b1b5628808d14e373e_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01 &#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2021, Cumberland Pharmaceuticals Inc. (the "Company" or "Tenant") entered into a lease (the "Lease"),  pursuant to which the Company will lease approximately 16,631 rentable square feet of space (the "Leased Premise") at the new development Broadwest (the "Building") located in Nashville, Tennessee  with 1600 West End Avenue Partners, LLC (the "Landlord").  The Leased Premise will serve as the Company's new corporate headquarters.  The initial term of the Lease is one hundred fifty-seven (157) months, with two consecutive options to renew for a period of five years each, and will commence on the earlier of November 1, 2022, the date which Tenant takes occupancy of the Leased Premise, or the date which Tenant receives a temporary or permanent certificate of occupancy for the Leased Premise ("Commencement Date").</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will be responsible for paying rent to the Landlord under the Lease beginning three months after the Commencement Date.  The Company will pay a base rent of $33.06 per square foot of rentable space with a gradual rental rate increase of 2.5% for each year period thereafter of the prior year's base rental.  In addition to the monthly base rent, the Company is responsible for its percentage share of the operating expenses of the Building.  The Lease also provides for a tenant improvement allowance for the space.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Lease is qualified in its entirety by reference to the Lease, a copy of which will be filed as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03&#160;&#160;&#160;&#160;Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.</span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 16, 2021, a press release was issued by Broadwest announcing its entry into the Lease as disclosed above under Item 1.01 of this Current Report on Form 8-K.  A copy of the press release is included as Exhibit 99.1 to this report.  </span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements or Exhibits</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:18.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11-19x21ex991.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a11-19x21ex991.htm">Press release dated November 16, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document) </span></td></tr></table></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div style="margin-top:11.25pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icd1614bd640146b1b5628808d14e373e_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:11.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:16.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 19, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Hamm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-19x21ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie7b7769546d24b99a294147417cf4b56_1"></div><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:363px"></div><div><font><br></font></div><div><img alt="image_1.jpg" src="image_1.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:358px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FOR IMMEDIATE RELEASE</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">November 16, 2021</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Cumberland Pharmaceuticals Moving Corporate Headquarters to Broadwest</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NASHVILLE, Tennessee </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212; Broadwest is pleased to announce it has entered into an agreement with Cumberland Pharmaceuticals Inc. to relocate the company&#8217;s corporate offices to the Broadwest campus in the West End&#47;Vanderbilt section of Nashville. Cumberland will establish its headquarters facility in the Broadwest office tower, with a move planned during 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cumberland</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (NASDAQ&#58; CPIX) </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> has emerged as the largest, public biopharmaceutical company founded and headquartered in Tennessee. The Company is focused on advancing patient care through the delivery of high quality medicines. Cumberland has built a portfolio of FDA approved brands supported by two national sales divisions. The Company also enjoys a robust pipeline of new medicines for the future, designed to address unmet medical needs. In addition to its domestic activities, Cumberland&#8217;s business includes a growing contribution from a network of distinguished international partners who are working to bring Cumberland brands to patients in their countries.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;We are delighted to be part of Nashville&#8217;s Health Care community, the largest industry sector in our area.&#8221; said A.J. Kazimi, Cumberland&#8217;s Chief Executive Officer. &#8220;Given our close collaboration with the internationally recognized Vanderbilt Medical Center, we wanted to stay in the West End corridor and look forward to working with Broadwest to join their beautiful new campus.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;We are pleased to welcome a great company like Cumberland Pharmaceuticals to the Broadwest community,&#8221; said Chris Brown, President of Propst Development, LLC .&#160;&#8220;As we worked with Cumberland on their new headquarters space, we learned a great deal about their passion to improve patient care through the development and distribution of high-quality medicines. From our first meeting, we knew they would be a great addition to the Broadwest campus.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Founded in 1999 in Nashville, Tennessee, Cumberland concluded its initial public offering and listing on the NASDAQ stock exchange in 2009. The Company&#8217;s Board of Directors and senior management team have many decades of experience in the health care and biopharmaceutical fields.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cumberland currently occupies space in the 2525 West End building near Vanderbilt. As the Company continues to grow its Nashville presence, it sought a new collaborative and professional work environment, resulting in the selection of Broadwest. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABOUT BROADWEST</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Broadwest is Nashville&#8217;s new $540-million, urban mixed-use community combining 625,000 square feet of Class A office and retail space, 196 high-end condominiums, and the 234-room luxury Conrad Nashville hotel all anchored by a 1.5-acre plaza at the heart of this new community. Propst Development, LLC is developing Broadwest, which recently opened the office tower and creative office </font></div><div style="height:40.01pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">building, began selling condominiums in mid-2021 and will open the Conrad Nashville Hotel in early 2022. For more information about Broadwest, write to info&#64;broadwestnashville.com.</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Designed by Cooper Carry architects, the Broadwest project opened its office tower, Creative Office Building, plaza and 2,500+ space parking garage for its first tenants earlier this year. The Creative Office Building features the quality of a Class A office building meshed with a focus on modern efficient space layout. Features include 18-foot floor-to-floor ceilings with stunning 14-foot floor-to-ceiling vision glass, upgraded construction design features for a collaborative work environment, an outdoor office tenant amenity space, a signature plaza space, the latest technology, and on-site security and access control for flexible work environments.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABOUT CUMBERLAND PHARMACEUTICALS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of branded prescription products to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care, gastroenterology and rheumatoid arthritis markets.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company's portfolio of FDA-approved brands includes&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Acetadote</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(acetylcysteine)&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Injection, for the treatment of acetaminophen poisoning&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Caldolor</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(ibuprofen)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Injection, for the treatment of pain and fever&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Kristalose</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(lactulose)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;for Oral Solution, a prescription laxative, for the treatment of constipation&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Omeclamox</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-Pak,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#160;(omeprazole, clarithromycin, amoxicillin)&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for the treatment of Helicobacter pylori&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(H. pylori)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;infection and related duodenal ulcer disease&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">RediTrex</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#160;(methotrexate)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Vaprisol</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#160;(conivaptan)&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.15pt">Vibativ</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(telavancin)&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cumberland also has Phase II clinical programs underway evaluating its product candidates in patients with cardiomyopathy associated with&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Duchenne Muscular Dystrophy</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;as well as patients with&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Systemic Sclerosis</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;and&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Aspirin-Exacerbated Respiratory Disease</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For more information on Cumberland&#8217;s approved products, including full prescribing information, please visit links to the individual product websites, which can be found on the Company&#8217;s website at </font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">www.cumberlandpharma.com </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Media Contacts&#58;</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Christopher Brown for Broadwest&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Molly Aggas for Cumberland</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(205) 706-6775, CBrown&#64;propst.com           </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                                    </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(704) 641 6641</font></div><div style="height:40.01pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cpix-20211119.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d9de5e93-697f-42b2-ad33-b7c537767821,g:b6819b24-3bab-4059-a559-788a40dfb1b8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpix="http://cumberlandpharma.com/20211119" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cumberlandpharma.com/20211119">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211119_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211119_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpix-20211119_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument">
        <link:definition>0001001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cpix-20211119_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d9de5e93-697f-42b2-ad33-b7c537767821,g:b6819b24-3bab-4059-a559-788a40dfb1b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20211119.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="i7531823fb7544dfdb90c48c9b19b50a9_DocumentandEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1d1b8e7d-376e-40f8-aad3-abbdd1e299a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_DocumentType_1d1b8e7d-376e-40f8-aad3-abbdd1e299a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e9c40b6b-2909-4eca-883b-642d82ebcc9b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_DocumentPeriodEndDate_e9c40b6b-2909-4eca-883b-642d82ebcc9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6163ab44-9b2b-4b38-a8b5-9a4f7ebfa8b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityRegistrantName_6163ab44-9b2b-4b38-a8b5-9a4f7ebfa8b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4ba9f378-6933-4d71-8cb5-d617caf5639a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityCentralIndexKey_4ba9f378-6933-4d71-8cb5-d617caf5639a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_66de6af2-d14b-4230-a082-1fca09829833" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_AmendmentFlag_66de6af2-d14b-4230-a082-1fca09829833" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_70c8c563-0d73-415c-9bda-c2d9722e82d1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_70c8c563-0d73-415c-9bda-c2d9722e82d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_07b0ccc6-9ee6-4029-8e17-7b08cd57995e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityFileNumber_07b0ccc6-9ee6-4029-8e17-7b08cd57995e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ee86f41f-ab65-4636-8b29-0f6cd596b79f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityTaxIdentificationNumber_ee86f41f-ab65-4636-8b29-0f6cd596b79f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fe8cdd79-8d47-4b50-bdd1-d33a70eb12d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_CityAreaCode_fe8cdd79-8d47-4b50-bdd1-d33a70eb12d0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f936b6a1-780a-45de-8d19-ef39a4cb750e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_LocalPhoneNumber_f936b6a1-780a-45de-8d19-ef39a4cb750e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_82133880-a964-4cc3-bacb-58f2b83bc061" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_WrittenCommunications_82133880-a964-4cc3-bacb-58f2b83bc061" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cffdcfbd-ab44-4bc7-9082-23938d4c29f8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_SolicitingMaterial_cffdcfbd-ab44-4bc7-9082-23938d4c29f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_dacb568a-68d2-4fd3-9a21-c4cb157f41ce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_PreCommencementTenderOffer_dacb568a-68d2-4fd3-9a21-c4cb157f41ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6c11277a-77bf-49b0-911a-c4222403b3dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6c11277a-77bf-49b0-911a-c4222403b3dc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_96c177cd-3888-4ee4-a4fa-242b7bb2045f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_Security12bTitle_96c177cd-3888-4ee4-a4fa-242b7bb2045f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3f12d232-73dc-4269-8a13-9ecde9dee692" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_TradingSymbol_3f12d232-73dc-4269-8a13-9ecde9dee692" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_291423af-e291-47ae-91bf-27a38e38f885" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_SecurityExchangeName_291423af-e291-47ae-91bf-27a38e38f885" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c3256209-4521-4e7a-beb4-0f8c8008687e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityEmergingGrowthCompany_c3256209-4521-4e7a-beb4-0f8c8008687e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_60dcb5f2-e182-4f4e-9b22-465c5211bc6b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressAddressLine1_60dcb5f2-e182-4f4e-9b22-465c5211bc6b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bffd23f4-5dbc-4935-9870-e3736ceb3672" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressPostalZipCode_bffd23f4-5dbc-4935-9870-e3736ceb3672" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_03f55d2e-e215-48dd-8bd8-18cf96ceb93d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressCityOrTown_03f55d2e-e215-48dd-8bd8-18cf96ceb93d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9af9b5b4-061e-4689-a0db-b8ddd00cc484" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressStateOrProvince_9af9b5b4-061e-4689-a0db-b8ddd00cc484" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f0653fbb-7517-4b87-9bd9-04b54c58b9e8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntitiesTable_f0653fbb-7517-4b87-9bd9-04b54c58b9e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cpix-20211119_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d9de5e93-697f-42b2-ad33-b7c537767821,g:b6819b24-3bab-4059-a559-788a40dfb1b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_1ea849c8-bbb7-42f1-8179-59a16fe9cc5f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2c5aa077-8bab-4a47-951b-21d8fbdeb821_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_21a29818-5e05-4dcb-bdd0-333bd2f5fd25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_63b0d6a0-b7a6-4eb4-8397-b052d09e68cd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a73c4ff0-27de-42e0-8337-22f7afc03295_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_29059cd1-a2b5-4fdd-a9e5-bb0a405fc76c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_efd6c74a-d637-421b-b413-481af1117ac2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c8d2df72-85e7-4e15-974c-e732cffc8bd7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0bcfb30e-e129-4457-a3f1-af3d2c47720a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1d3081e3-aa9e-4ec3-b71d-813b1f972813_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3b108ac5-521a-4955-a911-efdb822188a0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_f9aa6f70-9976-4960-a5e2-1b228739dca3_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ba83cb98-8276-483c-9034-52b2aa493323_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2f2a23f4-6293-487a-84fd-b975af3637ac_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2012a2ab-8d1a-49ae-9bc0-187d182592fc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d1ca48f9-fe0c-4340-a627-b344bd773b1d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_0c637271-ebdc-4d60-b103-4f60ea84c456_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_7f2ac8bd-d75c-4679-9260-689000729390_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0d8a26d0-a77f-4fbe-b4dc-a17363a8e560_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a71273a6-d326-4c35-9d48-ab89cae71dd0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_73cbf7cf-5d08-4697-9aa7-7c40c930e9ac_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_20fc0adc-972c-492c-9f3b-af06f900000d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_31a28e3c-cd5f-48bf-8b14-bd96c79f6c20_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_df2b5153-8370-47a3-ae19-a05aff7d4bab_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_621b92a9-6d49-4053-a20f-4e2295b9e6b2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cpix-20211119_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d9de5e93-697f-42b2-ad33-b7c537767821,g:b6819b24-3bab-4059-a559-788a40dfb1b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="cpix-20211119.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_59848503-72ea-48c5-bb2a-2ac8aa488cf0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f0653fbb-7517-4b87-9bd9-04b54c58b9e8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_59848503-72ea-48c5-bb2a-2ac8aa488cf0" xlink:to="loc_dei_EntitiesTable_f0653fbb-7517-4b87-9bd9-04b54c58b9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_f0653fbb-7517-4b87-9bd9-04b54c58b9e8" xlink:to="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1d1b8e7d-376e-40f8-aad3-abbdd1e299a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_DocumentType_1d1b8e7d-376e-40f8-aad3-abbdd1e299a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e9c40b6b-2909-4eca-883b-642d82ebcc9b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_DocumentPeriodEndDate_e9c40b6b-2909-4eca-883b-642d82ebcc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6163ab44-9b2b-4b38-a8b5-9a4f7ebfa8b8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityRegistrantName_6163ab44-9b2b-4b38-a8b5-9a4f7ebfa8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4ba9f378-6933-4d71-8cb5-d617caf5639a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityCentralIndexKey_4ba9f378-6933-4d71-8cb5-d617caf5639a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_66de6af2-d14b-4230-a082-1fca09829833" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_AmendmentFlag_66de6af2-d14b-4230-a082-1fca09829833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_70c8c563-0d73-415c-9bda-c2d9722e82d1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_70c8c563-0d73-415c-9bda-c2d9722e82d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_07b0ccc6-9ee6-4029-8e17-7b08cd57995e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityFileNumber_07b0ccc6-9ee6-4029-8e17-7b08cd57995e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ee86f41f-ab65-4636-8b29-0f6cd596b79f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityTaxIdentificationNumber_ee86f41f-ab65-4636-8b29-0f6cd596b79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fe8cdd79-8d47-4b50-bdd1-d33a70eb12d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_CityAreaCode_fe8cdd79-8d47-4b50-bdd1-d33a70eb12d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f936b6a1-780a-45de-8d19-ef39a4cb750e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_LocalPhoneNumber_f936b6a1-780a-45de-8d19-ef39a4cb750e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_82133880-a964-4cc3-bacb-58f2b83bc061" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_WrittenCommunications_82133880-a964-4cc3-bacb-58f2b83bc061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cffdcfbd-ab44-4bc7-9082-23938d4c29f8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_SolicitingMaterial_cffdcfbd-ab44-4bc7-9082-23938d4c29f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_dacb568a-68d2-4fd3-9a21-c4cb157f41ce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_PreCommencementTenderOffer_dacb568a-68d2-4fd3-9a21-c4cb157f41ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6c11277a-77bf-49b0-911a-c4222403b3dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6c11277a-77bf-49b0-911a-c4222403b3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_96c177cd-3888-4ee4-a4fa-242b7bb2045f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_Security12bTitle_96c177cd-3888-4ee4-a4fa-242b7bb2045f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3f12d232-73dc-4269-8a13-9ecde9dee692" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_TradingSymbol_3f12d232-73dc-4269-8a13-9ecde9dee692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_291423af-e291-47ae-91bf-27a38e38f885" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_SecurityExchangeName_291423af-e291-47ae-91bf-27a38e38f885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c3256209-4521-4e7a-beb4-0f8c8008687e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityEmergingGrowthCompany_c3256209-4521-4e7a-beb4-0f8c8008687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_60dcb5f2-e182-4f4e-9b22-465c5211bc6b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressAddressLine1_60dcb5f2-e182-4f4e-9b22-465c5211bc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bffd23f4-5dbc-4935-9870-e3736ceb3672" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressPostalZipCode_bffd23f4-5dbc-4935-9870-e3736ceb3672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_03f55d2e-e215-48dd-8bd8-18cf96ceb93d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressCityOrTown_03f55d2e-e215-48dd-8bd8-18cf96ceb93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9af9b5b4-061e-4689-a0db-b8ddd00cc484" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3169d1ab-740e-4856-ad2b-24b9a71a5d7c" xlink:to="loc_dei_EntityAddressStateOrProvince_9af9b5b4-061e-4689-a0db-b8ddd00cc484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "9 T(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:7XDT'4H1)8ZMHUZEQ!*",_>0D!AGE3@J>" :Z3(/&: "BBB@ HHHH ****
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M#-G.3)HFIA?FC9'^=8WP7C8[@5. S%&Q].9YQ0 4444 %%%% !1110 4444
M%%&<=:* "BBC('4T %%&:* "BBB@ HHSVH) ZF@ HH!SR** "BC(]:-P]: "
MBC.>110 4444 %%%&<=: "BBB@ HHHH **,CUHS0 44;AZT4 %%%% !111D>
MM !1110 4449STH ** P/0T4 %%%&1ZT %% (/0T4 %%%!..M !10&!X!HH
M***"0.IH ** P/0T9!. : "B@G'6C(/&: "BBB@ HHHH **"0.IHS0 44$@=
M31G/2@ HHHH ***,T %%&1ZT;AZT %%%% !1110 4444 %%&1G&:* "BBB@
MHHHH **** "BBB@ HHHH #TKQ_\ ;L_:X\$?L'?LB^//VL_B%;?:-/\ !>@R
M7D6G^9(GV^[8K%:VN](Y&C\VX>*(R;&$8<N1M4U[ >E?@G_P>P?M=7&F^%OA
M1^PUHURR_P!I32^,O$$3VH*R1QF2TLBDF>"&^V[EQR"AH _!_P"/_P =_BA^
MT[\:/$WQ_P#C1XJN-:\4>+-8FU+6=2N0BM+-(Q8@+&JHB@85415154*JJ  .
M/HK]XO\ @A5_P01_X)4_\%0O^">?A_\ :*^(%]\05\;6.M:AH/CJUT;Q"EM:
MV^H02^9&(UEM6)#6<]G*2&90\K*""I  /P=HK]%O^#C?_@D9\,?^"4G[1_@O
M1OV?O[9?P#XU\+//I\OB#5H[NZ&HVTVVZ4E(X]J;);4KD$DE^3C _.F@ HI5
M'/2O:/CM^Q_XO^"OP*\$_%[5;69?^$@@?^U('5\V<C'?"K H-F8R."22P;'%
M:QHU*D922VU9$ZM.G*,9/XM$>+448/3% X-9%A1TK]W?^"$'_!M-^R#^W/\
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MBOPSJGSS:-JD<<<DD'F@!;B,QRQ2),@ 9)%W+'('B3^1[_@J/^P3K'_!,_\
M;<\8?L>:Q\0;;Q3_ ,(W]EFL]<M[1K?[5:W-O'<0L\3%O+D\N1=RAF ;(#,,
M$_K%_P &.OB/[/XY_:/\+&W)^V:7X6NEDSPGDR:HI&/?SA_WS0!_0L"#TIL@
MSS0E*W;ZT ?S8?M+?\'?_P#P4Y^#?[1_Q ^$7A;X1_!.;3/"OC;5='T^:^\+
MZJ\SP6UY+#&TC+JBJ7*H"2%4$YP!TKB?^(TG_@JM_P!$:^!'_A)ZO_\ +6OS
M@_;O_P"3XOC-_P!E6\1?^G.XK]+?^"+_ /P;.?"/_@J3^Q#8_M7^,?VH=>\)
MWMYXCU#3&TC3_#L-S&JV[JH?>TRG)STQQ0!1_P"(TG_@JM_T1KX$?^$GJ_\
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M_P#Y:U].?\0-W@K_ *22:I_X:N/_ .65'_$#=X*_Z22:I_X:N/\ ^65 #O\
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M;6O_  =-XGNM2A;P_!X!2^6W^R7\]H")C>Q%MPAW_<&-V.<9/T=_Q W>"O\
MI))JG_AJX_\ Y94 ?,]I_P 'H'_!5.XNXX7^#7P)VR2*K$>$]7]?^PK7]*7[
M/GCS6?BG\!/!'Q.\16]O#J'B3PCINJ7T5FC+"DUQ:QS.J!BQ"AG. 23CJ3UK
M\2+;_@QW\&VMS'<#_@I#JK>7(&V_\*LCYP?^PE7[A_!SX?)\)/A%X5^%46J-
M?+X9\.6.DK?-#Y9N!;P)#YFS)V[MF<9.,XR: .DHHHH **** "BBB@ HHHH
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M_A'_ (?^#['1=.FNBK3/:V5LD*/(5 #2%8PS$ 98D]Z_C#_X*N?M?3_MU?\
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M;Q*EBRK>/X?T&XO!;EL[0YA1MI.TXSC.#CI70_\ #'7[77_1K'Q'_P#"'O\
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M  40_P""<O[/]O\ LT_LVZUX/@\,6NJ7.H11ZUX76ZG\Z=@TG[PN.,@8&.*
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MX*7?L(:/XF\37\?_  GW@O9H?CBV7(9[B-%\NY 8DE98]K9R?F)!.0:_*/\
MX/"?^":@^%/QMT?_ (*%_#+0MFB>.)!IWC;[/'A8-51?W<[>GFH,$GJRU\@_
M\&ZO_!2=O^"=/_!0?1KOQAK'V?P#\1/*\/>,U=L1P!W_ -%O&_ZY2M@DD )+
M(QS@4 ?V##I145I>6M[:QW=I.LD4D:O'(IR&4C((_"I: "OX:?\ @HU_RD)^
M/'_99O%'_IVN:_N6K^&G_@HU_P I"?CQ_P!EF\4?^G:YH _I&_X,]/\ E$%'
M_P!E.UK_ -!MJ_5"ORO_ .#/3_E$%'_V4[6O_0;:OU0H *#R,44'I0!^5_\
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M[I'[/7Q9MM)9M!TRZ\0:3>WW\,=Y<K930QGW:.TN&_X :_+;_@AC^W;\&/\
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M /1C7_F3/#'_ ,LZ/^(7'_@NO_T8U_YDSPQ_\LZ_K]HH _D"_P"(7'_@NO\
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M^"Z__1C7_F3/#'_RSH_XA<?^"Z__ $8U_P"9,\,?_+.OZ_:* /YN/^"%?_!
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M_!O[_P %B/".LWVD7/[!_C2]6QF>-K[3;>.:WE"G[\;A_F4]0<<BN/\ #_\
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M),0TLFTNS;0Q P.*]'1'#9;_ /50 JQ[3FG444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %# D8
M!HHH C6-Q_%2^6WK3Z* &A"&SBG444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[0*H4&AO=&]S:&]P(#,N,  X0DE-! 0
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M+" V,34M,CDW+3<W-C8L(')E8F5C8V% ;&]V96QL+F-O;1P"50 "2$\< EH
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ML*+>=GU-%9MJXHPET^:AIQI,EHD@*"7$I6.X/90![:UU5++3RN@F%G-R(_\
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MO)3>U_W<[K"]_$CRZJ=S%N4OMA0V0S$OFW;-I-2M2I+/1ZO+%/8RRM7F&G@
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MM*Y:5>MBB#;^J2IT[Y74^/6$.F,4AOPFU]QX"L]6/,?3JS[+[00X8)A,TG?
M M;A?6Y'-0&T&#2UYB]&0-TF][\;=!Y*[H&!JI*R+DAN1R.N)FD<;.Y^[>U&
M\=FV&]?E9J$MIQE^8W,3#DR/&##N(ZDYRE!."1E(P=>EP;784Z@BHZR!S]P
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MN!Z2%%;1X-+B$;&1$"Q.M^CH*KI!Y4G,"I<%F-&XL::Q'CMI::;15Z@$H2D
M) _L;R  &IP[1[.$W-&>YOS4.,#QP"PJ1WN^2\D_T?[B&XE:A&B;[<453N&W
M8[J7508CLVH]6#GV$R%-LH5\%%M6//!UD-M,-I1?#Z0-=S-AY7/B%\.RM=4$
M"LJ"6\LSYVLND_"+PAV/P1;)T^PK IBJ?1H*E/NN/.>+*J$A>/$D/N8'6ZK
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M+.:;QG5H )R9J/X25#T-3!2U#8H22QX -P1[0T.8'O:=:Z. Y&J,K:JP[6I
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#%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>cpix-20211119_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpix-20211119.xsd" xlink:type="simple"/>
    <context id="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087294</identifier>
        </entity>
        <period>
            <startDate>2021-11-19</startDate>
            <endDate>2021-11-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xMC9mcmFnOjYxZjRjM2E5YTc5ZDQzMzNhMWMyZTBiYWVkYzcxNTAzL3RhYmxlOmQ2YzdiNzRiNzg2ZTQ3YTdiYWIzMmQ0MWNiOGRkYWFlL3RhYmxlcmFuZ2U6ZDZjN2I3NGI3ODZlNDdhN2JhYjMyZDQxY2I4ZGRhYWVfMi0xLTEtMS0xMjAxNA_0d36e5d1-c96f-4507-9db3-816c70f6a717">0001087294</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xMC9mcmFnOjYxZjRjM2E5YTc5ZDQzMzNhMWMyZTBiYWVkYzcxNTAzL3RhYmxlOmQ2YzdiNzRiNzg2ZTQ3YTdiYWIzMmQ0MWNiOGRkYWFlL3RhYmxlcmFuZ2U6ZDZjN2I3NGI3ODZlNDdhN2JhYjMyZDQxY2I4ZGRhYWVfMy0xLTEtMS0xMjAxNA_9c2d463c-9b1f-488f-a6c9-12ef25165b3d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAx_06e7df26-a4c7-45ec-bee5-2f558c4d7794">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzc_4a7c2e20-66db-4572-98a1-4ac2ea4b9807">2021-11-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAy_5a261728-20cd-4d32-86b1-6fa8de77c4b1">CUMBERLAND PHARMACEUTICALS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTAtMS0xLTEyMDE0_edb3bafa-42c1-44d3-8d6c-03c3ffed22cd">TN</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTEtMS0xLTEyMDE0_757cf74e-0442-4168-b9c6-be9d590046e4">001-33637</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6M2MxMWNkZTc1NjM5NDg4ODllZjg3MzFhMmQyZWUwNmYvdGFibGVyYW5nZTozYzExY2RlNzU2Mzk0ODg4OWVmODczMWEyZDJlZTA2Zl8wLTMtMS0xLTEyMDE0_03db626d-c6c7-4ac0-9fc2-24207bdbcbfc">62-1765329</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk1_a45d2f15-8b68-4e8f-94a8-5d574d31d78b">2525 West End Avenue, Suite 950</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAz_c8a1152c-cc89-4527-a752-5ed334f71c8c">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk3_1fda035e-3fdb-4fbc-a56e-d2edc4ea49ed">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk4_d018e038-a362-4275-bf15-9bd9b2b73663">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk5_d2c34050-d5a8-483b-8b44-4788484c6fc5">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA0_8a1cdf4c-57b9-4c11-8672-122c2ffe9e1e">255-0068</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk2_9e6c407e-e172-417e-adfb-d2b8cf2c996f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNjk0_57ba37b3-2f04-4113-8db3-af27ebef0dc7">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA1_7258ea6c-720b-44e6-b475-3541790ef40c">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzA2_45d9f30d-c5e5-4ef4-b58d-8a01eee6809a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTAtMS0xLTEyMDE0_0723e2ba-aac5-4548-89cc-df3ac6f97292">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTEtMS0xLTEyMDE0_6f7a5966-7a3f-4a04-886c-0c576bbbde05">CPIX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGFibGU6ZDFlMWRhMzE3MzE4NGZhZjhlZmI1NjFhYmIxMzdjYzcvdGFibGVyYW5nZTpkMWUxZGEzMTczMTg0ZmFmOGVmYjU2MWFiYjEzN2NjN18xLTItMS0xLTEyMDE0_2118e7b5-4869-4982-9297-d69fb0af283a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8xNzAw_5ca26458-edce-423b-9a5e-5e7526086a4c">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119"
      id="id3VybDovL2RvY3MudjEvZG9jOmNkMTYxNGJkNjQwMTQ2YjFiNTYyODgwOGQxNGUzNzNlL3NlYzpjZDE2MTRiZDY0MDE0NmIxYjU2Mjg4MDhkMTRlMzczZV8xL2ZyYWc6NjY2MzBkZjEwNTUyNDQ1ZjkwNmUwMWIyZGYyM2QyZDkvdGV4dHJlZ2lvbjo2NjYzMGRmMTA1NTI0NDVmOTA2ZTAxYjJkZjIzZDJkOV8yMTk5MDIzMjU3Mjk5_5ca26458-edce-423b-9a5e-5e7526086a4c">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140189525637496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Nov. 19, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 19,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUMBERLAND PHARMACEUTICALS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1765329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-0068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2525 West End Avenue, Suite 950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M((IS4P[(+=_N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ ((IS4YE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  @BG-3F9H0
M74H$  !L$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ ((IS4Y^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  [1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cpix-20211119.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cumberlandpharma.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cpix-20211119.htm">cpix-20211119.htm</File>
    <File>a11-19x21ex991.htm</File>
    <File>cpix-20211119.xsd</File>
    <File>cpix-20211119_def.xml</File>
    <File>cpix-20211119_lab.xml</File>
    <File>cpix-20211119_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cpix-20211119.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "cpix-20211119_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cpix-20211119.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cpix-20211119_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpix-20211119_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cpix-20211119.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cpix",
   "nsuri": "http://cumberlandpharma.com/20211119",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20211119.htm",
      "contextRef": "i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document",
     "role": "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cpix-20211119.htm",
      "contextRef": "i0a3bc869edb640ad90e39c66d60ce13e_D20211119-20211119",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cumberlandpharma.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-21-023902-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-023902-xbrl.zip
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ML4"H*55G9-R8@^X- /@<Y24Y?V9:G*JE^3K%RM /(MSEPORI:&Y9,P?9Y\N
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MQXN?D?'>,@NNX-]/8!OE@_)A&=7[@S >@\0N(C!JQ>5E]'SI;<578KA5&4O
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M+?3W6?3NK8+7$U3>\&(VAG^Z63_<_!]02P,$%     @ ((IS4XFHJ%>3 @
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M8,)*O$,A.TFVXVPRH0Z%T93GH,W(E72U^?>IN,SOLCG%$.& QD $* 8A#R)
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M9/Q"'[U]L7TE7?_/C[<O_@]02P,$%     @ ((IS4[6QY28B!P  <#8  !4
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M>K?W?U!+ 0(4 Q0    ( ""*<U/2X>$2/0X  !Y+   2              "
M 0    !A,3$M,3EX,C%E>#DY,2YH=&U02P$"% ,4    "  @BG-3EQ92T!D7
M   RF0  $0              @ %M#@  8W!I>"TR,#(Q,3$Q.2YH=&U02P$"
M% ,4    "  @BG-3B:BH5Y,"  #9"   $0              @ &U)0  8W!I
M>"TR,#(Q,3$Q.2YX<V102P$"% ,4    "  @BG-3. #8K'4'   ",P  %0
M            @ %W*   8W!I>"TR,#(Q,3$Q.5]D968N>&UL4$L! A0#%
M  @ ((IS4XB4+Z I"P  P64  !4              ( !'S   &-P:7@M,C R
M,3$Q,3E?;&%B+GAM;%!+ 0(4 Q0    ( ""*<U.UL>4F(@<  ' V   5
M          "  7L[  !C<&EX+3(P,C$Q,3$Y7W!R92YX;6Q02P4&      8
,!@"' 0  T$(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
